Cardiology

Experimental antiplatelet compound for acute stroke shows promise

An experimental antiplatelet compound inhibited clot formation without increasing bleeding, a common and potentially dangerous side effect of current anticlotting therapies, according to new phase I research in Arteriosclerosis, ...

Oncology & Cancer

Cancer drug boosts levels of vascular-protective gene, KLF2

Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots.

page 6 from 8